Page last updated: 2024-09-05

1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium and oxytocin

1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium has been researched along with oxytocin in 1 studies

Compound Research Comparison

Studies
(1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium)
Trials
(1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium)
Recent Studies (post-2010)
(1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium)
Studies
(oxytocin)
Trials
(oxytocin)
Recent Studies (post-2010) (oxytocin)
50121,6111,8315,773

Protein Interaction Comparison

ProteinTaxonomy1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium (IC50)oxytocin (IC50)
Oxytocin receptorHomo sapiens (human)0.0027

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alcock, J; Goodson, YJ; Hill, SJ; Khan, RN; Lymn, JS; Warren, AY1

Other Studies

1 other study(ies) available for 1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium and oxytocin

ArticleYear
Inhibition of tissue transglutaminase 2 attenuates contractility of pregnant human myometrium.
    Biology of reproduction, 2011, Volume: 84, Issue:4

    Topics: Bradykinin; Cadaverine; Calcium Signaling; Cystamine; Enzyme Inhibitors; Female; GTP-Binding Proteins; Humans; Imidazoles; In Vitro Techniques; Myometrium; Norleucine; Obstetric Labor, Premature; Oxytocin; Phenylephrine; Pregnancy; Protein Glutamine gamma Glutamyltransferase 2; Tocolysis; Tocolytic Agents; Transglutaminases; Uterine Contraction

2011